Evotec Se - Adr (EVO) Live Share Price, Invest From India

Evotec Se - Adr Stock Performance

as on October 31, 2025 at 1:29 am IST

Day's Low
Day's High
$4.03
Day's Price Range
$4.12
$4.04
0.25%
Downside
1.98%
Upside
52 Week's Low
52 Week's High
$2.84
52-Week Price Range
$5.64
$4.04
29.70%
Downside
39.62%
Upside

Evotec Se - Adr share price movements today

Previous Close: $4.15
Open: $4.10
Volume: 250.8K
Day's Low - High: $4.03 - $4.12
52 Week Low - High: $2.84 - $5.64

Evotec Se - Adr Historical Returns

1 Month Return: + 7.98 %
3 Month Return: + 2.01 %
1 Year Return: + 4.91 %
3 Year Return: -58.26 %
5 Year Return: 0 %

Evotec Se - Adr Stock Fundamentals & Key Indicators

Check Evotec Se - Adr market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.5B

EPS (TTM)

-0.57

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

8.1M

Revenue (TTM)

777.3M

Profit Margin

-20.01%

Return On Equity TTM

-16.75%

Evotec Se - Adr vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Evotec Se - Adr with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Evotec Se - Adr	BUY	$1.5B	NA	NA	-20.01%
United Therapeutics Corporation	BUY	$20.5B	NA	17.21	40.65%
Haleon Plc Spon Ads	BUY	$40.8B	NA	20.11	13.81%
Neurocrine Biosciences Inc.	BUY	$13.8B	39.9%	33.02	15.95%
Zoetis Inc.	BUY	$63.9B	-9.11%	24.76	27.83%

Stock Returns calculator for Evotec Se - Adr Stock including INR - Dollar returns

The Evotec Se - Adr stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Evotec Se - Adr investment value today

Current value as on today

₹1,10,034

Returns

₹10,034

(+10.03%)

Returns from Evotec Se - Adr Stock

₹4,393 (+4.39%)

Dollar Returns*

₹5,642 (+5.64%)

Analyst Recommendation on Evotec Se - Adr Stock

Based on 16 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 16 analysts, 87.5% of analysts recommend a 'BUY' rating for Evotec Se - Adr. Average target price of $5.45

Evotec Se - Adr Share Price Target

Get share price movements and forecasts by analysts on Evotec Se - Adr.

What analysts predicted

25.87%UPSIDE

Target Price

$5.45

Current Price

$4.04

Analyzed by

16 Analysts

Target

$5.45

Evotec Se - Adr target price $5.45, a slight upside of 25.87% compared to current price of $4.04. According to 16 analysts rating.

Evotec Se - Adr Stock’s Investor Sentiment and Interest

Search interest for Evotec Se - Adr Stock has decreased by -21% in the last 30 days, reflecting a downward trend in search activity.

Time period: October 1, 2025 to October 31, 2025

Change:-21% versus previous 30 day period

Evotec Se - Adr Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	228	184	209	219	226	195	205	231	216	171
Gross Profit	56	50	40	41	37	16	20	48	29	8
Operating Income	12	-36	-12	-24	-27	-104	-26	8	-20	-27
EBITDA	-1	-17	-9	-11	-15	-103	-7	-	-27	-37
Interest Expense	2	2	3	3	2	2	1	4	2	5
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-6	-20	-29	-14	-25	-104	-46	-15	-29	-43
Income Tax Expense	7	-5	9	-7	-6	-9	-7	-	1	0
Net Income	-14	-16	-41	-17	-22	-102	-44	-42	-34	-43
Net Profit Margin	-6.51%	-8.77%	-19.85%	-8.01%	-9.90%	-52.13%	-21.44%	-18.46%	-15.79%	-25.39%

Evotec Se - Adr Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	138	173	304	427	496	609	698	795	781	833
Gross Profit	41	61	97	127	147	152	171	184	175	120
Operating Income	11	31	37	77	62	48	27	12	-107	-142
EBITDA	24	45	35	105	86	75	298	-86	-7	-80
Interest Expense	1	1	1	2	7	8	9	13	11	11
Depreciation	-	-	20	31	48	56	70	81	92	101
Income Before Tax	12	32	26	71	56	25	236	-153	-103	-193
Income Tax Expense	-4	6	2	-12	19	19	21	21	-40	2
Net Income	17	29	28	95	42	7	243	-185	-83	-205
Net Profit Margin	12.94%	16.73%	9.42%	22.42%	8.55%	1.25%	34.87%	-23.38%	-10.74%	-24.60%

Evotec Se - Adr Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-14	-38	-16	-20	-94	-39	-40	-31	-43
Operating Cash Flow	-6	20	18	-47	-50	42	74	-31	26
Investing Cash Flow	33	-15	-36	-31	-31	-25	-	-21	-21
Financing Cash Flow	13	43	30	-5	-119	-7	-29	35	-14
Change in Cash	46	39	11	-82	-206	9	61	-21	-17

Evotec Se - Adr Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	26	23	84	37	6	215	-175	-83	-196
Operating Cash Flow	67	10	156	42	44	122	203	33	18
Investing Cash Flow	-5	-269	-39	-86	-155	-243	-415	-	-71
Financing Cash Flow	-19	240	-77	211	246	398	-52	84	-161
Change in Cash	39	-16	42	167	145	276	-284	95	-204

Global Institutional Holdings in Evotec Se - Adr

Funds	Holdings
Mubadala Investment Company PJSC	1.29%
BlackRock Inc	0.38%
Wellington Management Company LLP	0.34%
DCF Advisers, LLC	0.31%
Morgan Stanley - Brokerage Accounts	0.11%

See all

Insights on Evotec Se - Adr

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 1 month, EVO stock has moved up by 11.8%
NO EFFECT
Against Peers
In the last 3 years, United Therapeutics Corporation has given 96.7% return, outperforming this stock by 155.0%
NO EFFECT
Against Peers
In the last 1 year, United Therapeutics Corporation has given 21.3% return, outperforming this stock by 16.4%
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, -31.57M → -43.47M (in $), with an average decrease of 37.7% per quarter
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 3 quarters, 221.22M → 171.23M (in $), with an average decrease of 12.0% per quarter

About Evotec Se - Adr

Evotec SE is a publicly listed drug discovery and development company headquartered in Hamburg, Germany. The company operates globally, largely through external alliances with pharmaceutical and biotechnology companies, academic institutions, patient advocacy groups, and venture capitalists.

Organisation	Evotec Se - Adr
Headquarters	Essener Bogen 7, Hamburg, Germany, 22419
Industry	Healthcare
CEO	Dr. Christian Wojczewski Ph.D.
E-voting on shares	Click here to vote

Key Management of Evotec Se - Adr

Name	Title
Dr. Ian M. Hunneyball	Senior Vice President of Programme Management & Clinical Operations
Dr. David Hallet	Executive Vice President
Ms. Christiane Honisch	SVP Head of Diagnostics
Dr. Cord Dohrmann Ph.D.	Chief Scientific Officer & Member of Management Board
Dr. Christian Dargel	EVP Global Head of Legal & Compliance
Mr. Paul Hitchin	CFO & Member of Management Board
Mr. Volker Braun	Executive VP and Head of Global Investor Relations & ESG
Uwe Andag	EVP Head of Metabolic Diseases
Dr. Christian Wojczewski Ph.D.	CEO & Management Board Member
Ms. Aurelie Dalbiez	Chief People Officer & Member of Management Board

FAQs

What is Evotec Se - Adr share price today?

Evotec Se - Adr share price today is $4.04 as on October 31, 2025 at 1:29 am IST at the close of the market. Evotec Se - Adr share today touched a day high of $4.12 and a low of $4.03.

What is the 52 week high and 52 week low for Evotec Se - Adr share?

Evotec Se - Adr share touched a 52 week high of $5.64 on November 15, 2024 and a 52 week low of $2.84 on April 7, 2025. Evotec Se - Adr stock price today i.e. October 31, 2025 at 1:29 am IST is closed at $4.04,which is 28.38% down from its 52 week high and 42.25% up from its 52 week low.

What is Evotec Se - Adr's market capitalisation today?

Evotec Se - Adr market capitalisation is $0.00T as on October 31, 2025 at 1:29 am IST.

How to invest in Evotec Se - Adr Stock (EVO) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Evotec Se - Adr on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Evotec Se - Adr Shares that will get you 0.3713 shares as per Evotec Se - Adr share price of $4.04 per share as on October 31, 2025 at 1:29 am IST.

What is the minimum amount required to buy Evotec Se - Adr Stock (EVO) from India?

Indian investors can start investing in Evotec Se - Adr (EVO) shares with as little as ₹88.665 or $1 (as of October 31, 2025 at 5:38 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹886.65 in Evotec Se - Adr stock (as per the Rupee-Dollar exchange rate as on October 31, 2025 at 5:38 pm IST). Based on Evotec Se - Adr share’s latest price of $4.04 as on October 31, 2025 at 1:29 am IST, you will get 2.4752 shares of Evotec Se - Adr. Learn more about fractional shares .